Please try another search
Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Technology, Financials and Utilities sectors led shares higher. At the close in NYSE, the Dow Jones Industrial...
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Vaxxinity, we, us or the Company) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines,...
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Vaxxinity, we, us or the Company) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines,...
HER-Vaxx antibodies outperform HerceptinImugene Ltd (ASX:IMU) has developed a more potent formulation of its therapeutic cancer vaccine, HER-Vaxx, which will be tested in a Phase Ib/II trial in...
Anti-tumour vaccine trial to start mid-2016 Imugene (AX:IMU) will test its reformulated therapeutic cancer vaccine, HER-Vaxx, in gastric cancer at trial sites in Asia. The Phase Ib/II trial is...
Imugene Ltd (AX:IMU) has in-licenced a pipeline of B-cell vaccines that complements and advances its in-house programme. The deal has brought forward significant value-creation opportunities while...
Instrument Type
Region
Sector
Industry
Date
Category
Provider